The Impact of Generic Clopidogrel Bisulfate on Platelet Inhibition in Patients with Coronary Artery Stents: Results of the ACCEL-GENERIC Study

BACKGROUND/AIMS: In patients with coronary artery stents, the cost of clopidogrel has been cited as a factor in the premature discontinuation of therapy. Thus, the introduction of lower-cost generic clopidogrel may increase patient compliance. However, platelet inhibition by generic clopidogrel has...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Young-Hoon, Koh, Jin-Sin, Kang, Min-Kyung, Ahn, Yeon-Jeong, Kim, In-Suk, Park, Yongwhi, Hwang, Seok-Jae, Kwak, Choong Hwan, Hwang, Jin-Yong
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880688/
https://www.ncbi.nlm.nih.gov/pubmed/20526388
http://dx.doi.org/10.3904/kjim.2010.25.2.154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880688/
https://www.ncbi.nlm.nih.gov/pubmed/20526388
http://dx.doi.org/10.3904/kjim.2010.25.2.154

Ejemplares similares